Apyx Medical (NASDAQ:APYX – Get Free Report) posted its earnings results on Friday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.01, Zacks reports. The company had revenue of $11.49 million during the quarter, compared to analyst estimates of $11.66 million. Apyx Medical had a negative return on equity of 105.45% and a negative net margin of 57.86%. During the same period in the previous year, the company earned ($0.13) EPS. Apyx Medical updated its FY 2025 guidance to EPS and its FY 2024 guidance to EPS.
Apyx Medical Price Performance
Shares of APYX traded down $0.04 on Monday, hitting $1.48. The company’s stock had a trading volume of 115,723 shares, compared to its average volume of 34,076. The company has a debt-to-equity ratio of 2.26, a current ratio of 5.33 and a quick ratio of 4.45. The firm’s fifty day moving average price is $1.21 and its 200-day moving average price is $1.33. Apyx Medical has a fifty-two week low of $0.97 and a fifty-two week high of $3.26.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on APYX shares. Craig Hallum upgraded Apyx Medical to a “strong-buy” rating in a research report on Thursday, October 24th. JMP Securities reiterated a “market perform” rating on shares of Apyx Medical in a research report on Monday, September 16th. Finally, BTIG Research assumed coverage on Apyx Medical in a research report on Thursday, October 17th. They issued a “neutral” rating for the company.
About Apyx Medical
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.
Featured Articles
- Five stocks we like better than Apyx Medical
- What is a support level?
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What is Insider Trading? What You Can Learn from Insider Trading
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Consumer Staples Stocks, Explained
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.
